Worldwide Immunoassay Industry Strategies and Trends to 2025 – Changing Technologies Spur Early Instrument Retirement –

Worldwide Immunoassay Industry Strategies and Trends to 2025 – Changing Technologies Spur Early Instrument Retirement –

Worldwide Immunoassay Industry Strategies and Trends to 2025 – Changing Technologies Spur Early Instrument Retirement –

DUBLIN–(BUSINESS WIRE)–The “Immunoassay Markets Strategies and Trends. Forecasts by Instrument Type and by Application and by Country. With Multiplex and Point of Care Market Analysis, Executive Guides and including Customized Forecasting and Analysis. 2021 to 2025” report has been added to’s offering.

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay.

Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. The publisher profiles 44 companies, large and small, working in this area.

Immunoassay Market – Strategic Situation Analysis & COVID Impact

  • Guide for Executives, Marketing, Sales and Business Development Staff
  • Guide for Management Consultants and Investment Advisors

Companies Mentioned

  • Abbott Diagnostics
  • Abcam
  • Arlington Scientific
  • Arrayit Corporation
  • Awareness Technology
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc
  • Biocartis
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • BioTek Instruments
  • Boditech Med, Inc
  • Boster Biological Technology
  • Diamedix (Erba Diagnostics)
  • Diasorin S.p.A
  • Dynex Technologies
  • Enzo Life Sciences, Inc
  • Eurofins Scientific
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • Gold Standard Diagnostics
  • Grifols
  • Hycor Biomedical
  • Immunodiagnostic Systems (IDS)
  • Immunodiagnostik AG
  • Inova Diagnostics
  • JR Biomedical
  • Luminex Corp
  • Maxim Biomedical
  • Meso Scale Discovery
  • Millipore Sigma
  • Mindray
  • Molecular Devices
  • MP Biomedical
  • MyCartis
  • Operon
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Qiagen Gmbh
  • Quidel
  • R&D Systems
  • Randox Toxicology
  • Roche Molecular Diagnostics
  • Serametrix
  • Siemens Healthineers
  • Sysmex
  • Tecan
  • Thermo Fisher Scientific Inc
  • TOSOH Bioscience

Key Topics Covered:

1. Introduction and Market Definition

2. Industry Overview

2.1 Industry Participants

2.1.1 IVD Supplier

2.1.2 Independent lab specialized/esoteric

2.1.3 Independent lab national/regional

2.1.4 Independent lab analytical

2.1.5 Public National/regional lab

2.1.6 Hospital lab

2.1.7 Physician lab

2.1.8 Audit body

2.2 The Clinical Laboratory Market Segments

2.2.1 Traditional Market Segmentation

2.2.2 Laboratory Focus and Segmentation

2.2.3 Hospital Testing Share

2.2.4 Economies of Scale Hospital vs. Central Lab

2.2.5 Physician Office Lab’s

2.2.6 Physician’s and POCT

2.3 Immunoassay -Markets and Discussion

3. Market Trends

3.1 Factors Driving Growth

3.1.1 Diagnostic Factors

3.1.2 Changing Technologies Spur Early Instrument Retirement.

3.1.3 Consumer Channels Open Wider

3.1.4 Immunity Technology Comes of Age

3.2 Factors Limiting Growth

3.2.1 Increased Competition Lowers Price

3.2.2 Threat from PCR Based Instruments

3.2.3 Lower Barriers to Entry

3.2.4 Wellness has a downside

3.3 Immunoassay Instrumentation

3.3.1 Instrumentation Tenacity.

3.3.2 Declining Cost of Instruments Changes Industry Structure.


3.3.4 Immunoassay – CRISPR Diagnostics

4. Immunoassay Recent Developments

4.1 Recent Developments – Importance and How to Use This Section

4.1.1 Importance of These Developments

4.1.2 How to Use This Section

  • COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing
  • Roche Diagnostics Expanding Testing Portfolio in 2021
  • PerkinElmer Long-Term Outlook
  • Quidel Updates Outlook for C19 Testing
  • Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza
  • Becton Dickinson and NAT Diagnostics Acquisition
  • New test diagnoses Lyme disease within 15 minutes
  • Multiplexed Immunoassay System Differentiates Malaria Species
  • ERBA Mannheim Unveils Next-Generation Nexus unit
  • Uman Diagnostics And Bio-Techne Announce Agreement For Neurofilament Light Assay
  • Software reduces variability in ELISA biomarker tests
  • Arrayit Corporation Allergy Testing Network Doubles
  • Expedeon Signs License Deal With Cell Guidance Systems for Biotin Tech
  • Efficacy Investigated for Electrochemiluminescence Immunoassay

5. Profiles of Key Companies

6. The Global Market

6.1 Global Market by Country

6.1.1 Global Market by Country Table

6.1.2 Global Market by Country Chart

6.2 Global Market by Application

6.2.1 Global Market by Application Table

6.2.2 Global Market by Application Segment Growth Chart

6.2.3 Global Market by Application Segment Annual Chart

6.2.4 Global Market by Application Segment Base vs. Final

6.2.5 Global Market by Application Base Year

6.2.6 Global Market by Application Final Year

6.3 Global Market by Technology

6.3.1 Global Market by Technology Table

6.3.2 Global Market by Technology Segment Growth Chart

6.3.3 Global Market by Technology Segment Annual Chart

6.3.4 Global Market by Technology Segment Base vs. Final

6.3.5 Global Market by Technology Base Year

6.3.6 Global Market by Application Final Year

7. Global Market by Application

8. Immunoassay by Technology

9. Vision of the Future of Immunoassay

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900